Skip to main content

Find Clinical Trials

Home
Conditions
Genital Neoplasms, Female

Clinical trial condition

Genital Neoplasms, Female

Explore clinical trials studying Genital Neoplasms, Female. Study availability and eligibility vary by location and protocol.

4,589 public trials 1,039 recruiting studies

Refine in advanced search Browse all conditions

Genital Neoplasms, Female trial results

Completed

Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia

NCT00054041

Conditions: Cervical Cancer, Cervical Intraepithelial Neoplasia Grade 3, Communicable Diseases, +26 more
Locations: Gynecologic Oncology Group Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Efficacy of Å6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels

NCT00083928

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
Locations: University of Alabama, Birmingham Birmingham, Alabama, United States

Desert Oasis Cancer Center Casa Grande, Arizona, United States

California Oncology of the Central Valley Fresno, California, United States

USC Keck School of Medicine Women's and Childrens Hospital Los Angeles, California, United States

View all 24 locations

View Trial Details

Completed

3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer

NCT00081276

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +20 more
Locations: Gynecologic Oncology Group Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Imatinib Mesylate in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer

NCT00036751

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +20 more
Locations: Southwest Oncology Group (SWOG) Research Base San Antonio, Texas, United States

View Trial Details

Completed

Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer

NCT00025467

Conditions: Endometrial Adenoacanthoma, Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, +15 more
Locations: Gynecologic Oncology Group Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer

NCT00002913

Conditions: Adnexal Diseases, Brenner Tumor, Carcinoma, +29 more
Locations: Gynecologic Oncology Group of Arizona Phoenix, Arizona, United States

View Trial Details

Completed

Tumor Vaccine and Interferon Gamma in Treating Patients With Refractory Epithelial Ovarian Cancer

NCT00004032

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +17 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Interleukin-12 in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer

NCT00016289

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +18 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment

NCT00008359

Conditions: Adnexal Diseases, Agranulocytosis, Amyloidosis, +141 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Efficacy and Safety Study of M200(Volociximab in Combination With Liposomal Doxorubicin)

NCT00635193

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: Site Reference ID/Investigator# 75281 Anaheim, California, United States

Site Reference ID/Investigator# 75275 Redondo Beach, California, United States

Site Reference ID/Investigator# 75296 Sunrise, Florida, United States

Site Reference ID/Investigator# 75299 Atlanta, Georgia, United States

View all 39 locations

View Trial Details